Veracyte (NASDAQ: VCYT) net income
Veracyte reported a net profit of $66.4m for fiscal 2025, 174.9% more than in fiscal 2024 ($24.1m). Its net margin was 12.8%. Earnings per share were $0.84.
Fiscal 2025 is the highest of the 10 fiscal years on record for Veracyte. It reported a loss in 8 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $66.4m | +174.9% | 12.8% | $0.84 |
| 2024 | $24.1m | — | 5.4% | $0.32 |
| 2023 | −$74.4m | — | −20.6% | −$1.02 |
| 2022 | −$36.6m | — | −12.3% | −$0.51 |
| 2021 | −$75.6m | — | −34.4% | −$1.11 |
| 2020 | −$34.9m | — | −29.7% | −$0.66 |
| 2019 | −$12.6m | — | −10.5% | −$0.27 |
| 2018 | −$23.0m | — | −25.0% | — |
| 2017 | −$31.0m | — | −43.1% | — |
| 2016 | −$31.4m | — | −48.2% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Veracyte net income compared with its sector
By net income for its latest fiscal year, Veracyte ranks 125th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Veracyte, 12.8%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 123rd | Nutex Health | $70.8m | 8.1% |
| 124th | UFP Technologies | $68.3m | 11.3% |
| 125th | Veracyte | $66.4m | 12.8% |
| 126th | Oramed Pharmaceuticals | $64.1m | 3,202.5% |
| 127th | Collegium Pharmaceutical | $62.9m | 8.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Veracyte
- How much did Veracyte earn in fiscal 2025?
- Veracyte reported a net profit of $66.4m for fiscal 2025. In fiscal 2024 it reported a net profit of $24.1m.
- What are the earnings per share of Veracyte?
- They were $0.84 in fiscal 2025, compared with $0.32 in fiscal 2024.
- What is the net margin of Veracyte?
- In fiscal 2025 its net profit was 12.8% of its revenue.
- What was the most profitable year for Veracyte?
- Of its last 10 fiscal years, fiscal 2025, with $66.4m.
- Where does Veracyte rank in its sector by net income?
- It ranks 125th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Veracyte come from?
- From the annual report (Form 10-K) that Veracyte files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Veracyte files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Veracyte: the Veracyte page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.